GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Omnicomm Systems Inc (OTCPK:OMCM) » Definitions » EV-to-EBIT

Omnicomm Systems (Omnicomm Systems) EV-to-EBIT : 58.10 (As of Apr. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Omnicomm Systems EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Omnicomm Systems's Enterprise Value is $65.42 Mil. Omnicomm Systems's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $1.13 Mil. Therefore, Omnicomm Systems's EV-to-EBIT for today is 58.10.

The historical rank and industry rank for Omnicomm Systems's EV-to-EBIT or its related term are showing as below:

OMCM's EV-to-EBIT is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 18.61
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Omnicomm Systems's Enterprise Value for the quarter that ended in Jun. 2019 was $45.19 Mil. Omnicomm Systems's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was $1.13 Mil. Omnicomm Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 was 2.49%.


Omnicomm Systems EV-to-EBIT Historical Data

The historical data trend for Omnicomm Systems's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omnicomm Systems EV-to-EBIT Chart

Omnicomm Systems Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.78 8.13 31.41 11.41 8.69

Omnicomm Systems Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.34 49.90 8.69 16.63 40.13

Competitive Comparison of Omnicomm Systems's EV-to-EBIT

For the Health Information Services subindustry, Omnicomm Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omnicomm Systems's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Omnicomm Systems's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Omnicomm Systems's EV-to-EBIT falls into.



Omnicomm Systems EV-to-EBIT Calculation

Omnicomm Systems's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=65.420/1.126
=58.10

Omnicomm Systems's current Enterprise Value is $65.42 Mil.
Omnicomm Systems's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnicomm Systems  (OTCPK:OMCM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Omnicomm Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2019 ) =EBIT / Enterprise Value (Q: Jun. 2019 )
=1.126/45.19002
=2.49 %

Omnicomm Systems's Enterprise Value for the quarter that ended in Jun. 2019 was $45.19 Mil.
Omnicomm Systems's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omnicomm Systems EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Omnicomm Systems's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Omnicomm Systems (Omnicomm Systems) Business Description

Traded in Other Exchanges
N/A
Address
2101 West Commercial Boulevard, Suite 3500, Fort Lauderdale, FL, USA, 33309
Omnicomm Systems Inc is a healthcare technology company. It provides web-based electronic data capture (EDC) and eClinical software and services. The company operates in one reportable segment which is the delivery of EDC software and services to clinical trial sponsors. The firm's EDC and eClinical software and service offerings consist of TrialMaster, TrialOne, Promasys, and eClinical Suite. Its other services include hosting, study design and development, training, consulting services, technology transfer and transition. The company serves clients in various industries including pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers.
Executives
Robert C Schweitzer director 1441 SW 29TH AVENUE, POMPANO BEACH FL 33069
Thomas E Vickers officer: Chief Financial Officer 2101 WEST COMMERCIAL BLVD, SUITE 3500, FORT LAUDERDALE FL 33309
Wit Cornelis F director, 10 percent owner, officer: Executive Chairman 2101 WEST COMMERCIAL BLVD., SUITE 3500, FORT LAUDERDALE FL 33309
Randall G Smith director, officer: Executive Vice Chairman 2101 WEST COMMERCIAL BLVD., SUITE 3500, FORT LAUDERDALE FL 33309
Ronald T Linares other: Former Officer
Michael Falk 10 percent owner 830 THIRD AVENUE, 4TH FLOOR, NEW YORK NY 10017